Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Holers, VM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kaya, Z; Afanasyeva, M; Wang, Y; Dohmen, KM; Schlichting, J; Tretter, T; Fairweather, D; Holers, VM; Rose, NR
      Contribution of the innate immune system to autoimmune myocarditis: a rolefor complement

      NATURE IMMUNOLOGY
    2. Springall, T; Sheerin, NS; Abe, K; Holers, VM; Wan, H; Sacks, SH
      Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli

      NATURE MEDICINE
    3. Boackle, SA; Holers, VM; Chen, XJ; Szakonyi, G; Karp, DR; Wakeland, EK; Morel, L
      Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein

      IMMUNITY
    4. Park, P; Haas, M; Cunningham, PN; Alexander, JJ; Bao, L; Guthridge, JM; Kraus, DM; Holers, VM; Quigg, RJ
      Inhibiting the complement system does not reduce injury in renal ischemia reperfusion

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    5. Schiller, B; Cunningham, PN; Alexander, JJ; Bao, LH; Holers, VM; Quigg, RJ
      Expression of a soluble complement inhibitor protects transgenic mice fromantibody-induced acute renal failure

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    6. Makar, KW; Ulgiati, D; Hagman, J; Holers, VM
      A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation

      INTERNATIONAL IMMUNOLOGY
    7. Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS
      Structure of complement receptor 2 in complex with its C3d ligand

      SCIENCE
    8. Ulgiati, D; Holers, VM
      CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor

      JOURNAL OF IMMUNOLOGY
    9. Guthridge, JM; Young, K; Gipson, MG; Sarrias, MR; Szakonyi, G; Chen, XJS; Malaspina, A; Donoghue, E; James, JA; Lambris, JD; Moir, SA; Perkins, SJ; Holers, VM
      Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: Identification of a highly inhibitory monoclonalantibody that directly recognizes the CR2-C3d interface

      JOURNAL OF IMMUNOLOGY
    10. Rehrig, S; Fleming, SD; Anderson, J; Guthridge, JM; Rakstang, J; McQueen, CE; Holers, VM; Tsokos, GC; Shea-Donohue, T
      Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal mesenteric ischemia/reperfusion damage after the onset ofinjury in mice

      JOURNAL OF IMMUNOLOGY
    11. Sekine, H; Reilly, CM; Molano, ID; Garnier, G; Circolo, A; Ruiz, P; Holers, VM; Boackle, SA; Gilkeson, GS
      Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice

      JOURNAL OF IMMUNOLOGY
    12. Henson, SE; Smith, D; Boackle, SA; Holers, VM; Karp, DR
      Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function

      JOURNAL OF IMMUNOLOGICAL METHODS
    13. Guthridge, JM; Rakstang, JK; Young, KA; Hinshelwood, J; Aslam, M; Robertson, A; Gipson, MG; Sarrias, MR; Moore, WT; Meagher, M; Karp, D; Lambris, JD; Perkins, SJ; Holers, VM
      Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg

      BIOCHEMISTRY
    14. Holers, VM
      Phenotypes of complement knockouts

      IMMUNOPHARMACOLOGY
    15. Cunningham, PN; Holers, VM; Alexander, JJ; Guthridge, JM; Carroll, MC; Quigg, RJ
      Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure

      KIDNEY INTERNATIONAL
    16. Xu, CG; Mao, DL; Holers, VM; Palanca, B; Cheng, AM; Molina, H
      A critical role for murine complement regulator Crry in fetomaternal tolerance

      SCIENCE
    17. Marchbank, KJ; Watson, CC; Ritsema, DF; Holers, VM
      Expression of human complement receptor 2 (CR2, CD21) in Cr2(-/-) mice restores humoral immune function

      JOURNAL OF IMMUNOLOGY
    18. Watanabe, H; Garnier, G; Circolo, A; Wetsel, RA; Ruiz, P; Holers, VM; Boackle, SA; Colten, HR; Gilkeson, GS
      Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B

      JOURNAL OF IMMUNOLOGY
    19. Holers, VM
      Complement

      PRINCIPLES OF MOLECULAR RHEUMATOLOGY
    20. Holers, VM
      Complement as a regulatory and effector pathway in human diseases

      THERAPEUTIC INTERVENTIONS IN THE COMPLEMENT SYSTEM
    21. Karp, DR; Carlisie, ML; Mobley, AB; Nichols, TC; Oppenheimer-Marks, N; Brezinschek, RI; Holers, VM
      gamma-Glutamyl transpeptidase is up-regulated on memory T lymphocytes

      INTERNATIONAL IMMUNOLOGY
    22. Davoust, N; Nataf, S; Holers, VM; Barnum, SR
      Expression of the murine complement regulatory protein Crry by glial cellsand neurons

      GLIA
    23. Alexander, JJ; Lim, A; He, C; MacDonald, RL; Holers, VM; Quigg, RJ
      Renal, central nervous system and pancreatic overexpression of recombinantsoluble Crry in transgenic mice. A novel means of protection from complement-mediated injury

      IMMUNOPHARMACOLOGY
    24. Henson, SE; Nichols, TC; Holers, VM; Karp, DR
      The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes

      JOURNAL OF IMMUNOLOGY
    25. Nardin, A; Schlimgen, R; Holers, VM; Taylor, RP
      A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver ina mouse model

      EUROPEAN JOURNAL OF IMMUNOLOGY
    26. Holers, VM
      Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus

      ARTHRITIS AND RHEUMATISM
    27. MOLLINA H; HOLERS VM; FANG YF
      DEFICIENCY OF COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 ON FOLLICULAR DENDRITIC CELLS RESULTS IN AN IMPAIR ANTIGEN-SPECIFIC IGG RESPONSE

      The FASEB journal
    28. QUIGG RJ; HE C; LIM A; HOLERS VM
      TRANSGENIC MICE OVEREXPRESSING SOLUBLE CRRY ARE PROTECTED FROM ANTIBODY-INDUCED GLOMERULAR INJURY

      The FASEB journal
    29. HOLERS VM; KOZONO Y; BERTHIAUME D; LIM A; SALANT D; KREMMER E; OUIGG RJ
      BLOCKADE OF ANTIBODY-INDUCED GLOMERULONEPHRITIS WITH CRRY-IG, A SOLUBLE MURINE COMPLEMENT INHIBITOR

      The FASEB journal
    30. GILKESON GS; GARNIER G; CIRCOLO A; WETSEL R; HOLERS VM; FEAGIN A; COLTEN HR
      MODULATION OF RENAL-DISEASE IN LUPUS MICE DEFICIENT IN COMPLEMENT COMPONENT C3

      Molecular immunology
    31. WATANABE H; CIRCOLO A; WETSEL R; HOLERS VM; BOACKLE SA; COLTEN HR; GILKESON GS
      AMELIORATION OF RENAL-DISEASE IN LUPUS MICE GENETICALLY DEFICIENT IN COMPLEMENT FACTOR-B

      Molecular immunology
    32. GUTHRIDGE JM; ASLAM M; PERKINS SJ; HOLERS VM
      STRUCTURAL-ANALYSIS OF RECOMBINANT HUMAN CD21 LIGAND-BINDING DOMAINS

      Molecular immunology
    33. KELLY RG; MOLINA H; WALDSCHMIDT T; DALPORTO J; HOLERS VM
      CR1 CR2 DEFICIENT MICE FAIL TO MAINTAIN GERMINAL-CENTERS FOLLOWING INTRAVENOUS IMMUNIZATION/

      Molecular immunology
    34. HOLERS VM; BOACKLE SA; JIANG N; JEONG CH; MOLINA H
      ROLE OF COMPLEMENT RECEPTORS TYPE-2 (CR2 CD21) AND TYPE-1 (CR1/CD35) IN MURINE LUPUS/

      Molecular immunology
    35. MARCHBANK KJ; HOLERS VM
      EXPRESSION OF HUMAN-COMPLEMENT RECEPTOR-2 (HCR2) IN TRANSGENIC MICE

      Molecular immunology
    36. MAKAR KW; HOLERS VM
      TRANSCRIPTIONAL REGULATION OF HUMAN CR2 CD21 GENE-EXPRESSION/

      Molecular immunology
    37. MCNEARNEY T; DIERICH M; WANG D; PHAM C; HOLERS VM
      MODULATION OF CR-2 (CD21) BY HTLV-I REGULATORY GENES

      Molecular immunology
    38. MOLINA H; MAO D; HOLERS VM; COLTEN H; XU C
      FETAL LOSS AND IMPAIRED FETOMATERNAL TOLERANCE IN MICE DEFICIENT IN CRRY, A MURINE REGULATOR OF C3 ACTIVATION

      Molecular immunology
    39. ASLAM M; GUTHRIDGE JM; QUIGG RJ; HOLERS VM; PERKINS SJ
      DIFFERENT SCR DOMAIN ARRANGEMENTS IN HUMAN FACTOR-H AND MOUSE AND RATCRRY BY X-RAY AND NEUTRON SOLUTION SCATTERING AND CONSTRAINED HOMOLOGY MODELING

      Molecular immunology
    40. QUIGG RJ; LIM A; SCHILLER B; HE C; BERTHIAUME D; ALEXANDER JJ; KRAUS D; HOLERS VM
      TRANSGENIC MICE OVEREXPRESSING CRRY AS A RECOMBINANT SOLUBLE-PROTEIN ARE PROTECTED FROM COMPLEMENT-MEDIATED RENAL INJURY

      Molecular immunology
    41. QUIGG RJ; KOZONO Y; BERTHIAUME D; LIM A; SALANT DJ; WEINFELD A; GRIFFIN P; KREMMER E; HOLERS VM
      BLOCKADE OF ANTIBODY-INDUCED GLOMERULONEPHRITIS WITH CRRY-IG, A SOLUBLE MURINE COMPLEMENT INHIBITOR

      The Journal of immunology
    42. KOZONO Y; ABE R; KOZONO H; KELLY RG; AZUMA T; HOLERS VM
      CROSS-LINKING CD21 CD35 OR CD19 INCREASES BOTH B7-1 AND B7-2 EXPRESSION ON MURINE SPLENIC B-CELLS/

      The Journal of immunology
    43. MAKAR KW; PHAM CTN; DEHOFF MH; OCONNOR SM; JACOBI SM; HOLERS VM
      AN INTRONIC SILENCER REGULATES B-LYMPHOCYTE CELL-SPECIFIC AND STAGE-SPECIFIC EXPRESSION OF THE HUMAN-COMPLEMENT RECEPTOR-TYPE 2 (CR-2, CD21) GENE

      The Journal of immunology
    44. FANG YF; XU CG; FU YX; HOLERS VM; MOLINA H
      EXPRESSION OF COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 ON FOLLICULAR DENDRITIC CELLS IS NECESSARY FOR THE GENERATION OF A STRONG ANTIGEN-SPECIFIC IGG RESPONSE

      The Journal of immunology
    45. Boackle, SA; Morris, MA; Holers, VM; Karp, DR
      Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells

      JOURNAL OF IMMUNOLOGY
    46. QUIGG RJ; HE C; LIM A; BERTHIAUME D; ALEXANDER JJ; KRAUS D; HOLERS VM
      TRANSGENIC MICE OVEREXPRESSING THE COMPLEMENT INHIBITOR CRRY AS A SOLUBLE-PROTEIN ARE PROTECTED FROM ANTIBODY-INDUCED GLOMERULAR INJURY

      The Journal of experimental medicine
    47. Nichols, TC; Guthridge, JM; Karp, DR; Molina, H; Fletcher, DR; Holers, VM
      gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes

      EUROPEAN JOURNAL OF IMMUNOLOGY
    48. HOLERS VM; HE C; LIM A; BERTHIAUME D; ALEXANDER JJ; KRAUS D; OUIGG RJ
      TRANSGENIC MICE OVEREXPRESSING THE COMPLEMENT INHIBITOR CRRY ARE PROTECTED FROM ANTIBODY-INDUCED GLOMERULAR INJURY

      Arthritis and rheumatism
    49. GIKESON GS; GARRNIER G; CIRCOLO A; WETSEL R; HOLERS VM; FEAGIN A; COLTEN HR
      MODULATION OF RENAL-DISEASE IN LUPUS MICE DEFICIENT IN COMPLEMENT COMPONENT C3

      Arthritis and rheumatism
    50. KEARNSJONKER M; MONELLTORRENS E; ABBASI F; HOLERS VM; NOTKINS AL; SIGOUNAS G
      EBV BINDS TO LYMPHOCYTES OF TRANSGENIC MICE THAT EXPRESS THE HUMAN CR-2 GENE

      Virus research
    51. NICHOLS TC; GUTHRIDGE J; FLETCHER D; HOLERS VM
      A ROLE FOR GAMMA-GLUTAMYL-TRANSPEPTIDASE IN CD19 CD21 COMPLEX FUNCTION/

      Journal of allergy and clinical immunology
    52. MAKAR KW; PHAM CT; DEHOFF M; OCONNOR S; JACOBI S; HOLERS VM
      AN INTRONIC SILENCER REGULATES B-LYMPHOCYTE CELL AND STAGE-SPECIFIC EXPRESSION OF THE HUMAN-COMPLEMENT RECEPTOR-TYPE-2 (CR2,CD21) GENE

      Journal of allergy and clinical immunology
    53. ALEXANDER JJ; HE C; ADLER S; HOLERS VM; QUIGG RJ
      CHARACTERIZATION OF C3 RECEPTORS ON CULTURED RAT GLOMERULAR ENDOTHELIAL-CELLS

      Kidney international
    54. TAKAHASHI K; KOZONO Y; WALDSCHMIDT TJ; BERTHIAUME D; QUIGG RJ; BARON A; HOLERS VM
      MOUSE COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-2 (CR-2, CD21) - EXPRESSION ON NORMAL B-CELL SUBPOPULATIONS AND DECREASED LEVELS DURING THE DEVELOPMENT OF AUTOIMMUNITY IN MRL LPR MICE/

      The Journal of immunology
    55. KAWAMOTO Y; KOJIMA K; HITSUMOTO Y; OKADA H; HOLERS VM; MIYAMA A
      THE SERUM RESISTANCE OF MALARIA-INFECTED ERYTHROCYTES

      Immunology
    56. BOACKLE SA; HOLERS VM; KARP DR
      CD21 AUGMENTS ANTIGEN PRESENTATION IN IMMUNE INDIVIDUALS

      European Journal of Immunology
    57. HOLERS VM; KARP DR; GUTHRIDGE JM; NICHOLS TC
      GAMMA-GLUTAMYL-TRANSPEPTIDASE (GGT), A REGULATOR OF INTRACELLULAR REDOX POTENTIAL, IS PHYSICALLY ASSOCIATED WITH THE B-LYMPHOCYTE CD21 CD19/TM4 SIGNAL-TRANSDUCTION COMPLEX/

      Arthritis and rheumatism
    58. KARP DR; NICHOLS TC; OPPENHEIMERMARKS NE; HOLERS VM
      GAMMA-GLUTAMYL-TRANSPEPTIDASE IS A MARKER FOR A MEMORY T-LYMPHOCYTE POPULATION EXPANDED IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    59. BOACKLE SA; HOLERS VM; KARP DR
      CD21 AUGMENTS ANTIGEN PRESENTATION IN IMMUNE INDIVIDUALS

      The FASEB journal
    60. SAWANTMANE S; PIDDLESDEN SJ; MORGAN BP; HOLERS VM; KOSKI CL
      CD59 HOMOLOG REGULATES COMPLEMENT-DEPENDENT CYTOLYSIS OF RAT SCHWANN-CELLS

      Journal of neuroimmunology
    61. MOLINA H; HOLERS VM; LI B; FANG YF; MARIATHASAN S; GOELLNER J; STRAUSSSCHOENBERGER J; KARR RW; CHAPLIN DD
      MARKEDLY IMPAIRED HUMORAL IMMUNE-RESPONSE IN MICE DEFICIENT IN COMPLEMENT RECEPTOR-1 AND RECEPTOR-2

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. KOZONO Y; KOTZIN BL; HOLERS VM
      RESTING B-CELLS FROM NEW-ZEALAND BLACK MICE DEMONSTRATE A DEFECT IN APOPTOSIS INDUCTION FOLLOWING SURFACE IGM LIGATION

      The Journal of immunology
    63. ROGERS CA; GASQUE P; PIDDLESDEN SJ; OKADA N; HOLERS VM; MORGAN BP
      EXPRESSION AND FUNCTION OF MEMBRANE REGULATORS OF COMPLEMENT ON RAT ASTROCYTES IN CULTURE

      Immunology
    64. BOACKLE SA; MORRIS MA; HOLERS VM; KAM DR
      AUGMENTED B-CELL ANTIGEN PRESENTATION BY CD21 DOES NOT INVOLVE B-CELLACTIVATION

      Arthritis and rheumatism
    65. KOZONO Y; KOTZIN BL; HOLERS VM
      RESTING B-CELLS FROM NZB MICE DEMONSTRATE A DEFECT IN APOPTOSIS INDUCTION FOLLOWING SIGM LIGATION

      Arthritis and rheumatism
    66. MOLINA H; HOLERS VM; FANG YF; CHAPLIN DD
      IMPAIRED FOLLICULAR TRAPPING OF IMMUNE-COMPLEXES IN THE SPLEEN OF MICE DEFICIENT IN COMPLEMENT RECEPTOR-1 AND RECEPTOR-2

      Arthritis and rheumatism
    67. QUIGG RJ; LO CF; BERTHIAUME D; KOZONO Y; HOLERS VM
      EXPRESSION OF COMPLEMENT-RECEPTOR-1 (CR-1) AND COMPLEMENT (C) INHIBITORS IN MRL LPR LUPUS MICE/

      Journal of the American Society of Nephrology
    68. HOLERS VM; DEHOFF M; MAKAR K; PHAM C
      APPROPRIATE ACTIVITY OF THE PROMOTER FOR HUMAN CR-2 REQUIRES CHROMOSOMAL INTEGRATION AND AN INTRONIC REGULATOR

      The FASEB journal
    69. QUIGG RJ; HOLERS VM
      CHARACTERIZATION OF RAT COMPLEMENT RECEPTORS AND REGULATORY PROTEINS

      The FASEB journal
    70. DEHOFF M; PHAM C; OCONNOR S; JACOBI S; MAKAR K; HOLERS VM
      APPROPRIATE ACTIVITY OF THE PROMOTER FOR HUMAN CD21 REQUIRES CHROMOSOMAL INTEGRATION

      Journal of cellular biochemistry
    71. KOZONO Y; DUKE RC; SCHLEICHER MS; HOLERS VM
      CO-LIGATION OF MOUSE COMPLEMENT RECEPTOR-2 AND RECEPTOR-1 (CR-2 AND CR-1) WITH SIGMA RESCUES SPLENIC B-CELLS ADN WEHI-231 CELLS FROM ANTI-SIGMA INDUCED APOPTOSIS

      Journal of cellular biochemistry
    72. QUIGG RJ; MORGAN BP; HOLERS VM; ADLER S; SNEED AE; LO CF
      COMPLEMENT REGULATION IN THE RAT GLOMERULUS - CRRY AND CD59 REGULATE COMPLEMENT IN GLOMERULAR MESANGIAL AND ENDOTHELIAL-CELLS

      Kidney international
    73. SHIMA M; TEITELBAUM SL; HOLERS VM; RUZICKA C; OSMACK P; ROSS FP
      MACROPHAGE-COLONY-STIMULATING FACTOR REGULATES EXPRESSION OF THE INTEGRINS ALPHA(4)BETA(1) AND ALPHA(5)BETA(1) BY MURINE BONE-MARROW MACROPHAGES

      Proceedings of the National Academy of Sciences of the United Statesof America
    74. QUIGG RJ; HOLERS VM
      CHARACTERIZATION OF RAT COMPLEMENT RECEPTORS AND REGULATORY PROTEINS - CR-2 AND CRRY ARE CONSERVED, AND THE C3B RECEPTOR OF NEUTROPHILS ANDPLATELETS IS DISTINCT FROM CR-1

      The Journal of immunology
    75. QUIGG RJ; HOLERS VM; MORGAN BP; SNEED AE
      CRRY AND CD59 REGULATE COMPLEMENT IN RAT GLOMERULAR EPITHELIAL-CELLS AND ARE INHIBITED BY THE NEPHRITOGENIC ANTIBODY OF PASSIVE HEYMANN NEPHRITIS

      The Journal of immunology
    76. MOLINA H; PERKINS SJ; GUTHRIDGE J; GORKA J; KINOSHITA T; HOLERS VM
      CHARACTERIZATION OF A COMPLEMENT RECEPTOR-2 (CR2, CD21) LIGAND-BINDING SITE FOR C3 - AN INITIAL MODEL OF LIGAND INTERACTION WITH 2 LINKED SHORT CONSENSUS REPEAT MODULES

      The Journal of immunology
    77. DUNSTER LM; SCHNEIDERSCHAULIES J; DEHOFF MH; HOLERS VM; SCHWARTZALBIEZ R; TERMEULEN V
      MOESIN, AND NOT THE MURINE FUNCTIONAL HOMOLOG (CRRY P65) OF HUMAN MEMBRANE COFACTOR PROTEIN (CD46), IS INVOLVED IN THE ENTRY OF MEASLES-VIRUS (STRAIN EDMONSTON) INTO SUSCEPTIBLE MURINE CELL-LINES/

      Journal of General Virology
    78. KIM YU; KINOSHITA T; MOLINA H; HOURCADE D; SEYA T; WAGNER LM; HOLERS VM
      MOUSE COMPLEMENT REGULATORY PROTEIN CRRY P65 USES THE SPECIFIC MECHANISMS OF BOTH HUMAN DECAY-ACCELERATING FACTOR AND MEMBRANE COFACTOR PROTEIN/

      The Journal of experimental medicine
    79. BOUILLIE S; BAREL M; DRANE P; CASSINAT B; BALBO M; HOLERS VM; FRADE R
      EPSTEIN-BARR-VIRUS C3D RECEPTOR (CR2, CD21) ACTIVATED BY ITS EXTRACELLULAR LIGANDS REGULATES PP105 PHOSPHORYLATION THROUGH 2 DISTINCT PATHWAYS

      European Journal of Immunology
    80. KOZONO Y; DUKE RC; SCHLEICHER MS; HOLERS VM
      CO-LIGATION OF MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 WITH SURFACE IGM RESCUES SPLENIC B-CELLS AND WEHT-231 CELLS FROM ANTISURFACE IGM-INDUCED APOPTOSIS

      European Journal of Immunology
    81. BOACKLE SA; HOLERS VM; KARP DR
      COMPLEMENT RECEPTOR-2 ON ANTIGEN-PRESENTING CELLS AUGMENTS T-CELL RECOGNITION IN IMMUNE INDIVIDUALS

      Arthritis and rheumatism
    82. HOLERS VM; KINOSHITA T; MOLINA H
      IDENTIFICATION AND ANALYSIS OF FUNCTIONAL DOMAINS OF MOUSE COMPLEMENTRECEPTOR-1 AND RECEPTOR-2

      Journal of cellular biochemistry
    83. MOLINA H; KINOSHITA T; WEBSTER CB; HOLERS VM
      ANALYSIS OF C3B C3D BINDING-SITES AND FACTOR-I COFACTOR REGIONS WITHIN MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2/

      The Journal of immunology
    84. AUBRY JP; POCHON S; GAUCHAT JF; NUEDAMARIN A; HOLERS VM; GRABER P; SIEGFRIED C; BONNEFOY JY
      CD23 INTERACTS WITH A NEW FUNCTIONAL EXTRACYTOPLASMIC DOMAIN INVOLVING N-LINKED OLIGOSACCHARIDES ON CD21

      The Journal of immunology
    85. GRAHAM IL; ANDERSON DC; HOLERS VM; BROWN EJ
      COMPLEMENT RECEPTOR-3 (CR3, MAC-1, INTEGRIN-ALPHA(M)BETA(2), CD11B CD18) IS REQUIRED FOR TYROSINE PHOSPHORYLATION OF PAXILLIN IN ADHERENT AND NONADHERENT NEUTROPHILS/

      The Journal of cell biology
    86. HOLERS VM; HOLLIS GF; SCHWARTZ BD; EVANS RJ; STRAUSSSCHOENBERGER J; CAREL JC; BARNEY DL; LI B; STAFFORDHOLLIS J; LACY PE
      INDUCTION OF PERI-INSULITIS BUT NOT DIABETES IN ISLET TRANSPLANTS EXPRESSING A SINGLE FOREIGN ANTIGEN - A MULTISTAGE MODEL OF DISEASE

      The Journal of immunology
    87. LI B; SALLEE C; DEHOFF M; FOLEY S; MOLINA H; HOLERS VM
      MOUSE CRRY P65 - CHARACTERIZATION OF MONOCLONAL-ANTIBODIES AND THE TISSUE DISTRIBUTION OF A FUNCTIONAL HOMOLOG OF HUMAN MCP AND DAF/

      The Journal of immunology
    88. MOLINA HD; BRENNER C; KINOSHITA T; HOLERS VM
      IDENTIFICATION OF C3 BINDING-SITES WITHIN HUMAN-COMPLEMENT RECEPTOR-2(CR-2)

      The Journal of immunology
    89. FOLEY S; LI B; DEHOFF M; MOLINA H; HOLERS VM
      MOUSE CRRY P65 - DEMONSTRATION OF ALTERNATIVE PATHWAY REGULATORY CAPACITY AND CHARACTERIZATION OF MABS/

      The Journal of immunology
    90. PHAM CT; OCONNOR SM; DEHOFF MH; JACOBI SM; HOLERS VM
      TRANSCRIPTIONAL REGULATION OF HUMAN-COMPLEMENT RECEPTOR-2 (CR-2)

      The Journal of immunology
    91. BOACKLE S; HOLERS VM; KARP D
      PRESENCE OF CR-2 ON ANTIGEN PRESENTING CELLS ENHANCES T-CELL RECOGNITION

      The Journal of immunology
    92. FOLEY S; LI B; DEHOFF M; MOLINA H; HOLERS VM
      MOUSE CRRY P65 IS A REGULATOR OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION/

      European Journal of Immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 05:14:05